APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 260 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $403,642 | +51.2% | 6,867 | +54.0% | 0.00% | – |
| Q4 2023 | $266,976 | -24.3% | 4,460 | +15.2% | 0.00% | – |
| Q2 2023 | $352,830 | -63.5% | 3,873 | -73.5% | 0.00% | -100.0% |
| Q1 2023 | $965,522 | +32.5% | 14,638 | +3.9% | 0.00% | 0.0% |
| Q4 2022 | $728,439 | +75.5% | 14,087 | +132.0% | 0.00% | 0.0% |
| Q3 2022 | $415,000 | +52.6% | 6,071 | +0.9% | 0.00% | – |
| Q2 2022 | $272,000 | -9.6% | 6,014 | +1.4% | 0.00% | – |
| Q1 2022 | $301,000 | +7.5% | 5,931 | 0.0% | 0.00% | – |
| Q4 2021 | $280,000 | – | 5,931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |